Arrowhead Pharmaceuticals
- Market cap
- 8.68B
- P/E (TTM)i
- -26.96
- P/Bi
- 18.65
- EPSi
- -0.01
- Div yieldi
- 0.00%
- 52W posi
- 44%
Anonymous reader poll. Unscientific, not investment advice.
Arrowhead Pharmaceuticals shares were changing hands at 61.48, down 0.10% on the day. Its market capitalisation is about 8.68B, the #1569 most valuable US-listed company we track. The 12 analysts covering the stock are, on balance, at Buy, targeting an average of 109.11 (+77%). The shares sit 44% of the way up their 52-week range of 34.61 to 95.49.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 weeks.
- Recent price momentum is +19.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 6.6% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 61.54
- Open
- 61.63
- Day range
- 60.78 - 62.75
- Avg price
- 61.55
- Volume
- 1.82M
- Turnover
- 111.99M
- Turnover ratei
- 1.49%
- Volume ratioi
- 1.05
- Amplitudei
- 3.20%
- 52-week rangei
- 34.61 - 95.49
Valuation
- P/Ei
- -6,148.00
- P/E (TTM)i
- -26.96
- P/Bi
- 18.65
- EPSi
- -0.01
- Book value / shi
- 3.30
- Net profit
- -1.41M
- Net assets
- 465.57M
Share structure
- Market cap
- 8.68B
- Float capi
- 7.53B
- Shares out
- 141.25M
- Float sharesi
- 122.45M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
35.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-3.17M net over the window
Short interest
- Shares short
- 9.27M
- % of floati
- 6.56%
- Days to coveri
- 5.15
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Arrowhead Pharmaceuticals (ARWR)?
Arrowhead Pharmaceuticals last traded at 61.48. The quote on this page refreshes every few seconds while US markets are open.
What is Arrowhead Pharmaceuticals's market cap?
About 8.68B.
What is the P/E ratio of Arrowhead Pharmaceuticals?
The trailing twelve-month P/E is -26.96. The Valuation tab shows it against the stock's own five-year range.
Does Arrowhead Pharmaceuticals pay a dividend?
Arrowhead Pharmaceuticals does not currently pay a regular dividend.
Is Arrowhead Pharmaceuticals a buy according to analysts?
The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 109.11, which implies 77.5% upside from the current price. This is not investment advice.
What is Arrowhead Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Arrowhead Pharmaceuticals a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 07:06:10 · For reference only, not investment advice and not tailored to your situation.